BRITISH NEURO-ONCOLOGY SOCIETY
Promoting research and raising awareness of neuro-oncology, treatments and techniques. Advocating for the interests of brain cancer patients and carers. Advancing education via an Annual Scientific Meeting.
Objects
THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH FOR PATIENTS SUFFERING WITH TUMOURS OF THE BRAIN AND CENTRAL NERVOUS SYSTEM BY IMPROVING TREATMENT THROUGH:A. EDUCATING THE PUBLIC IN GENERAL (PARTICULARLY MEDICAL PRACTITIONERS, NURSES, ALLIED HEALTH PROFESSIONALS, AND THE WIDER SCIENTIFIC COMMUNITY IN THE UNITED KINGDOM) ON THE SUBJECT OF NEURO-ONCOLOGY; B. PROMOTING RESEARCH FOR THE PUBLIC BENEFIT IN ALL ASPECTS OF NEURO-ONCOLOGY AND PUBLISHING THE USEFUL RESULTS; C. RAISING AWARENESS OF NEURO-ONCOLOGY AND OF TREATMENTS AND TECHNIQUES IN CLINICAL PRACTICE AMONG THE GENERAL PUBLIC, HEALTH PROFESSIONALS AND POLICY MAKERS; D. GENERAL ADVOCACY FOR THE INTERESTS OF BRAIN CANCER PATIENTS, THEIR FAMILIES AND CARERS.
Financial health, per its FY2025 accounts
The accounts state that the charity held £107,661 in unrestricted cash funds at the end of the period, a decrease from £130,185 in the prior year. The trustees consider there are no uncertainties about the charity continuing as a going concern. The charity aims to hold more than 12 months of operational spend in unrestricted cash reserves, equivalent to approximately £45,000.
What the accounts disclose
“Income is raised through membership fees and additional revenue is generated through the annual conference.”
“The charity aims to hold more than 12 months of operational spend in unrestricted cash reserves, equivalent to approximately £45,000 at 24/25 levels.”
Policies the charity declares
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/05/2025
- Volunteers: 45
Self-declared on the annual return for the financial year ending 31/05/2024
- Volunteers: 45
Trustees
- Victoria Anne Skinnerchair
- Catherine Elisabeth Fraher
- Dr Harpreet Kaur Hyare
- Professor Colin Watts MBBS PhD
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/05/2025 | £26k | £49k |
| 31/05/2024 | £177k | £47k |
Common questions
Is BRITISH NEURO-ONCOLOGY SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity held £107,661 in unrestricted cash funds at the end of the period, a decrease from £130,185 in the prior year. The trustees consider there are no uncertainties about the charity continuing as a going concern. The charity aims to hold more than 12 months of operational spend in unrestricted cash reserves, equivalent to approximately £45,000. Its FY2025 accounts were independently examined.
Charities like this
- THE BRITISH NEUROPATHOLOGICAL SOCIETY
- BRITISH NUCLEAR MEDICINE SOCIETY
- THE BRITISH ASSOCIATION OF HEAD AND NECK ONCOLOGISTS
- BRITISH SOCIETY OF NEURORADIOLOGISTS
- BRITISH THORACIC ONCOLOGY GROUP
- BRITISH SOCIETY FOR NEUROENDOCRINOLOGY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| BRITISH NEURO-ONCOLOGY SOCIETY | £26k | — | 0 | above | — | no doubt |
| THE BRITISH NEUROPATHOLOGICAL SOCIETY | £181k | — | 0 | above | — | no doubt |
| BRITISH NUCLEAR MEDICINE SOCIETY | £625k | — | 0 | above | — | no doubt |
| THE BRITISH ASSOCIATION OF HEAD AND NECK ONCOLOGISTS | £240k | — | 0 | unclear | — | no doubt |
| BRITISH SOCIETY OF NEURORADIOLOGISTS | £145k | — | 0 | above | — | no doubt |
| BRITISH THORACIC ONCOLOGY GROUP | £1.7m | — | 0 | unclear | — | no doubt |